Novel biomaterial prevents rejection of transplants for type 1 diabetes: Clinical trial is planned based on results from preclinical study.

A team develops a novel biomaterial that, when mixed with islets, allows islets to survive after transplant without the need for long-term immunosuppression.

Leave a Comment